Cargando…

Influence of methotrexate, leflunomide and tumour necrosis factor alpha inhibitors on immune competence in rheumatoid arthritis patients: a long-run monitoring of Epstein–Barr virus load

Detalles Bibliográficos
Autores principales: Balandraud, N, Guis, S, Meynard, JB, Auger, I, Sovran, H, Roudier, J, Roudier, C
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2005
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2834156/
http://dx.doi.org/10.1186/ar1678
_version_ 1782178554334674944
author Balandraud, N
Guis, S
Meynard, JB
Auger, I
Sovran, H
Roudier, J
Roudier, C
author_facet Balandraud, N
Guis, S
Meynard, JB
Auger, I
Sovran, H
Roudier, J
Roudier, C
author_sort Balandraud, N
collection PubMed
description
format Text
id pubmed-2834156
institution National Center for Biotechnology Information
language English
publishDate 2005
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-28341562010-03-08 Influence of methotrexate, leflunomide and tumour necrosis factor alpha inhibitors on immune competence in rheumatoid arthritis patients: a long-run monitoring of Epstein–Barr virus load Balandraud, N Guis, S Meynard, JB Auger, I Sovran, H Roudier, J Roudier, C Arthritis Res Ther Poster Presentation BioMed Central 2005 2005-02-17 /pmc/articles/PMC2834156/ http://dx.doi.org/10.1186/ar1678 Text en Copyright ©2005 BioMed Central Ltd
spellingShingle Poster Presentation
Balandraud, N
Guis, S
Meynard, JB
Auger, I
Sovran, H
Roudier, J
Roudier, C
Influence of methotrexate, leflunomide and tumour necrosis factor alpha inhibitors on immune competence in rheumatoid arthritis patients: a long-run monitoring of Epstein–Barr virus load
title Influence of methotrexate, leflunomide and tumour necrosis factor alpha inhibitors on immune competence in rheumatoid arthritis patients: a long-run monitoring of Epstein–Barr virus load
title_full Influence of methotrexate, leflunomide and tumour necrosis factor alpha inhibitors on immune competence in rheumatoid arthritis patients: a long-run monitoring of Epstein–Barr virus load
title_fullStr Influence of methotrexate, leflunomide and tumour necrosis factor alpha inhibitors on immune competence in rheumatoid arthritis patients: a long-run monitoring of Epstein–Barr virus load
title_full_unstemmed Influence of methotrexate, leflunomide and tumour necrosis factor alpha inhibitors on immune competence in rheumatoid arthritis patients: a long-run monitoring of Epstein–Barr virus load
title_short Influence of methotrexate, leflunomide and tumour necrosis factor alpha inhibitors on immune competence in rheumatoid arthritis patients: a long-run monitoring of Epstein–Barr virus load
title_sort influence of methotrexate, leflunomide and tumour necrosis factor alpha inhibitors on immune competence in rheumatoid arthritis patients: a long-run monitoring of epstein–barr virus load
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2834156/
http://dx.doi.org/10.1186/ar1678
work_keys_str_mv AT balandraudn influenceofmethotrexateleflunomideandtumournecrosisfactoralphainhibitorsonimmunecompetenceinrheumatoidarthritispatientsalongrunmonitoringofepsteinbarrvirusload
AT guiss influenceofmethotrexateleflunomideandtumournecrosisfactoralphainhibitorsonimmunecompetenceinrheumatoidarthritispatientsalongrunmonitoringofepsteinbarrvirusload
AT meynardjb influenceofmethotrexateleflunomideandtumournecrosisfactoralphainhibitorsonimmunecompetenceinrheumatoidarthritispatientsalongrunmonitoringofepsteinbarrvirusload
AT augeri influenceofmethotrexateleflunomideandtumournecrosisfactoralphainhibitorsonimmunecompetenceinrheumatoidarthritispatientsalongrunmonitoringofepsteinbarrvirusload
AT sovranh influenceofmethotrexateleflunomideandtumournecrosisfactoralphainhibitorsonimmunecompetenceinrheumatoidarthritispatientsalongrunmonitoringofepsteinbarrvirusload
AT roudierj influenceofmethotrexateleflunomideandtumournecrosisfactoralphainhibitorsonimmunecompetenceinrheumatoidarthritispatientsalongrunmonitoringofepsteinbarrvirusload
AT roudierc influenceofmethotrexateleflunomideandtumournecrosisfactoralphainhibitorsonimmunecompetenceinrheumatoidarthritispatientsalongrunmonitoringofepsteinbarrvirusload